SciELO - Scientific Electronic Library Online

vol.36 número 3Análisis molecular de familias uruguayas con Enfermedad de Huntington índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



Links relacionados


Archivos de Medicina Interna

versión impresa ISSN 0250-3816versión On-line ISSN 1688-423X


PINEIRO, Natalia; PERNA, Abayubá; BALDIZZONI, Marcela  y  CORREA, Fernando. Analysis of a Uruguayan cohort of patients with Glioblastoma treated with radiotherapy and Temozalamide. Arch. Med Int [online]. 2014, vol.36, n. 3, pp.133-136. ISSN 0250-3816.

Objectives: find out the two-year survival of patients diagnosed with Multiform Glioblastoma (MGB) treated with Temozolamide funded by the National Resource Fund (FNR), and evaluate the safety of therapy and prognostic factors. Methodology: cohort of patients with MGB, treated with Temozolamide between May 2009 and December 2011. Data source: database of the FNR. Results: the 81 patients included had a median overall survival of 18 months; 33  of them were still alive at two years. The multivariate analysis found that the patient’s age and functional status were the risk factors for mortality. Eight patients had severe adverse effects. Discussion: Presentation of the first national results related to the combined therapy of MGB. Survival was similar to that reported in the international reference studies and greater than that described for radiation therapy alone. Benefits were greater in young patients presenting with a good functional capacity before starting therapy. The safety of therapy was deemed acceptable.

Palabras clave : Multiform glioblastoma; Temozolamide.

        · resumen en Español     · texto en Español


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons